Business of Healthcare

Are pharmaceutical makers becoming outcomes companies? with AJ Ploszay, Ph.D. (GlaxoSmithKline) Brad Ansley (SPI Health)

05.29.2018 - By Matthew HanisPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Digital is disrupting pharmaceutical companies at their very core: product development and commercial operations.  We explore this with two leaders deep in the thick of transforming this key healthcare segment . . . 10% of the overall healthcare spend in the US . . . as digital innovation destroys and recreates the industry.

More episodes from Business of Healthcare